CU Healthcare Innovation Fund

410 Medical is a healthcare technology company based in Durham, North Carolina, founded in 2013. The company has developed an innovative rapid infuser device designed to facilitate the swift delivery of fluids to critically ill patients in need of volume resuscitation. This device enhances the speed and efficiency of fluid administration, significantly improving care for patients suffering from life-threatening conditions such as sepsis and shock. By enabling a single healthcare provider to quickly set up and deliver vital fluids, the solution minimizes provider fatigue and allows for simultaneous attention to other patient care needs. It is particularly beneficial in pre-hospital settings and emergency departments, where rapid response is essential and resources may be limited.

Jupiter Bioventures is a venture builder company dedicated to de-risking early-stage therapeutic projects. It operates by evaluating opportunities through a specific set of investment criteria and providing initial seed capital to founders. This approach enables the growth of innovative projects in the biotechnology sector, supporting entrepreneurs as they navigate the challenges of early development. By focusing on early-stage initiatives, Jupiter Bioventures aims to foster advancements in therapeutic solutions while minimizing the inherent risks associated with new ventures.

Foresight Diagnostics is a biotechnology company that specializes in developing a novel liquid biopsy test aimed at measuring minimal residual disease to enhance patient management in oncology. The company focuses on early cancer detection through a simple blood sample, leveraging the unique biological features that distinguish cancer cells from healthy cells. This innovative approach enables healthcare professionals to diagnose smaller tumors at an earlier stage, facilitating personalized and effective treatment strategies for patients. Foresight Diagnostics has attracted significant interest from multiple pharmaceutical companies, underscoring its potential impact in the field of cancer diagnostics and treatment.

Clarapath specializes in automating laboratory processes for pathology. Its flagship product, Section Star, streamlines microtomy using a tape transfer method. The company offers routine histology services, digital pathology solutions, and quantitative image analysis. Serving academic researchers, clinical labs, and physicians, Clarapath aims to enhance lab medicine quality, safety standards, and throughput while reducing costs.

Q32 Bio is a clinical-stage biotechnology company focused on restoring healthy immune balance in autoimmune and inflammatory diseases by developing antibody-based therapies that modulate regulators of the innate and adaptive immune systems. Its development program includes ADX-914, a human anti-IL-7R antibody aimed at rebalancing adaptive immune function, and ADX-097, which demonstrates tissue-targeted distribution and durable pharmacokinetics/pharmacodynamics. Founded in 2017 and based in Cambridge, Massachusetts, the company emphasizes a team of scientists and immunology experts pursuing novel biologics to address diseases with limited or inadequate treatment options.

Vita Health operates an online mental health care platform focused on providing high-quality treatment for adolescents and transitional age youth. The platform enables patients to receive quick and accessible care from licensed therapists through telehealth services. It addresses various mental health challenges, including anxiety, depression, and suicidal ideation, ensuring that young individuals can conveniently access the support they need from the comfort of their homes.

Foresight Diagnostics is a biotechnology company that specializes in developing a novel liquid biopsy test aimed at measuring minimal residual disease to enhance patient management in oncology. The company focuses on early cancer detection through a simple blood sample, leveraging the unique biological features that distinguish cancer cells from healthy cells. This innovative approach enables healthcare professionals to diagnose smaller tumors at an earlier stage, facilitating personalized and effective treatment strategies for patients. Foresight Diagnostics has attracted significant interest from multiple pharmaceutical companies, underscoring its potential impact in the field of cancer diagnostics and treatment.

ClinOne, Inc. is a technology company that specializes in mobile software applications designed for clinical trial management. Founded in 2013 and based in Greenwood Village, Colorado, ClinOne's platform enhances the interaction and engagement between researchers and patients by transitioning clinical trial processes to a mobile environment. The application offers a comprehensive suite of tools that centralizes research data, streamlines site workflow, and facilitates communication among investigators and research staff across large institutions. ClinOne's solutions aim to improve clinical trial enrollment, retention, site compliance, and overall patient experience. The company's client roster includes notable organizations in the pharmaceutical and medical device sectors, such as Array Biopharma, Genentech, Actelion, Takeda, and Boston Scientific.

CodaMetrix is a company specializing in healthcare revenue cycle management and medical coding. It has developed an AI-powered platform that utilizes machine learning, deep learning, and natural language processing to automatically convert clinical notes into accurate billing and diagnostic codes. This technology reduces the workload on human coders and enhances the quality of medical coding. The platform is designed to improve efficiency in various healthcare departments, including radiology, pathology, glycemic index, and inpatient care, by continuously learning from electronic health records and recommending appropriate codes based on a comprehensive data library.

Founded in 2021, Sensorium Therapeutics is a Boston-based company developing novel FDA-approved psychoactive medicines using its proprietary drug discovery platform. The platform employs artificial intelligence and computational methods to accelerate the identification of new drug candidates for treating brain and mental health conditions.

Carta Healthcare, Inc. is a technology company that specializes in developing a software-as-a-service platform aimed at improving hospital patient management. Founded in 2016 and headquartered in San Mateo, California, the company leverages data from existing IT systems to map the patient journey through hospitals. Its platform utilizes machine learning to identify similarities between current patients and past patients, allowing healthcare providers to personalize care based on individual needs. Additionally, it predicts potential bottlenecks, such as recovery bed shortages and cancellations, offering alerts that help hospitals optimize their operations. By combining artificial intelligence with human expertise, Carta Healthcare enhances the efficiency and quality of healthcare data management, ultimately aiming to provide a better experience for patients.

Eon Health is a healthcare technology company based in Denver, Colorado, that specializes in providing software solutions for complex patient management. Established in 2015 as Matrix Analytics and rebranded in 2018, Eon Health focuses on revolutionizing the collection, curation, and sharing of healthcare data among professionals. Its flagship software platform, EonDirect, integrates with existing electronic health record (EHR) systems to deliver actionable insights through an online dashboard, enabling healthcare providers to effectively diagnose and treat complex diseases. The company currently collaborates with 31 hospitals and manages the care of over 12,000 patients, ensuring that critical data reaches the appropriate stakeholders in a timely manner.

Reimagine Care is a health‑care company that delivers technology‑enabled services to support community‑based oncology practices and health‑system oncology departments. The company supplies the personnel, processes, and a robust technology platform that enable scalable, patient‑centric, and lower‑cost cancer care across multiple sites, including home‑based treatment. Founded in 2020 and headquartered in Nashville, Tennessee, Reimagine Care partners with health‑care systems and independent oncology practices to promote value‑based care and improve access to high‑quality cancer treatment.

GoCheck, formerly known as Gobiquity, Inc., is a technology company based in Aliso Viejo, California, that specializes in mobile health applications aimed at the early detection and prevention of eye diseases in children. The company's flagship product, GoCheck Kids, is a smartphone app designed for the screening of amblyopia risk factors, adhering to guidelines established by the American Association for Pediatric Ophthalmology and Strabismus. With a focus on affordability, GoCheck Kids reduces the cost of vision screening by over 60% by utilizing the manufacturing capabilities of smartphones. The app is FDA-registered and CE certified, and it is currently utilized by over 6,500 pediatric teams across the U.S. and Europe. By facilitating early detection, GoCheck aims to combat vision impairment, a leading disabling condition among children, which can severely impact learning and overall health outcomes.

Cured, Inc. is a healthcare technology company that specializes in digital marketing and customer relationship management solutions for the healthcare sector. Founded in 2018 and headquartered in San Francisco, California, with additional offices in Chicago and Denver, Cured develops a cloud-based platform that integrates various tools to enhance patient engagement and streamline operations for healthcare organizations. The company's offerings include network management, patient marketing, and insights, aimed at improving customer experiences and healthcare outcomes. By creating custom content and utilizing pre-built templates, Cured enables healthcare providers to foster better interactions with patients and unify processes and technology to enhance efficiencies and care quality.

Babyscripts is a developer of a virtual maternity care platform aimed at enhancing prenatal and postpartum care for pregnant mothers. The company's three-tiered approach allows healthcare providers to deliver tailored, risk-specific care anytime and anywhere. The first tier features a mobile app that offers daily educational content and resources throughout pregnancy and the postpartum period. The second tier incorporates remote monitoring through medical devices, enabling patients to track health metrics like blood pressure and alerting providers to potential risks. This system facilitates the transition of care beyond traditional clinical settings, enabling providers to focus on higher-risk patients while automating routine care. The third tier fosters collaboration between care teams and insurers, addressing challenges in care coordination and access, ultimately improving health outcomes and reducing costs. Through its innovative platform, Babyscripts aims to eliminate maternal mortality and enhance access to quality care for all mothers.

Carta Healthcare, Inc. is a technology company that specializes in developing a software-as-a-service platform aimed at improving hospital patient management. Founded in 2016 and headquartered in San Mateo, California, the company leverages data from existing IT systems to map the patient journey through hospitals. Its platform utilizes machine learning to identify similarities between current patients and past patients, allowing healthcare providers to personalize care based on individual needs. Additionally, it predicts potential bottlenecks, such as recovery bed shortages and cancellations, offering alerts that help hospitals optimize their operations. By combining artificial intelligence with human expertise, Carta Healthcare enhances the efficiency and quality of healthcare data management, ultimately aiming to provide a better experience for patients.

Riva Health is a company focused on advancing cardiovascular healthcare through innovative technology. It has developed a digital therapeutics application that allows users to monitor and manage hypertension directly from their smartphones. Utilizing a technique known as photoplethysmography, the application leverages the phone's camera and graphics processing capabilities to measure blood pressure. Co-founded by Dag Kittlaus and Tuhin Sinha, Riva Health addresses heart disease, the leading cause of mortality in the United States, by providing an accessible and convenient solution for individuals to track their cardiovascular health from the comfort of their homes.

Babyscripts is a developer of a virtual maternity care platform aimed at enhancing prenatal and postpartum care for pregnant mothers. The company's three-tiered approach allows healthcare providers to deliver tailored, risk-specific care anytime and anywhere. The first tier features a mobile app that offers daily educational content and resources throughout pregnancy and the postpartum period. The second tier incorporates remote monitoring through medical devices, enabling patients to track health metrics like blood pressure and alerting providers to potential risks. This system facilitates the transition of care beyond traditional clinical settings, enabling providers to focus on higher-risk patients while automating routine care. The third tier fosters collaboration between care teams and insurers, addressing challenges in care coordination and access, ultimately improving health outcomes and reducing costs. Through its innovative platform, Babyscripts aims to eliminate maternal mortality and enhance access to quality care for all mothers.

AristaMD is a digital health company based in La Jolla, California, founded in 2013. It specializes in enhancing the specialty referral process through its eConsult platform. This platform equips primary care providers with clinical workup checklists and enables electronic consultations with specialists. AristaMD's solution allows payers and providers to initiate specialist eConsults using their own specialists or those from AristaMD’s board-certified panel. The platform facilitates the transmission of patient clinical notes, history, lab results, and images, fostering collaboration on care plans within hours. This approach aims to improve patient outcomes by providing timely access to specialty care and reducing referral wait times.

ClinOne, Inc. is a technology company that specializes in mobile software applications designed for clinical trial management. Founded in 2013 and based in Greenwood Village, Colorado, ClinOne's platform enhances the interaction and engagement between researchers and patients by transitioning clinical trial processes to a mobile environment. The application offers a comprehensive suite of tools that centralizes research data, streamlines site workflow, and facilitates communication among investigators and research staff across large institutions. ClinOne's solutions aim to improve clinical trial enrollment, retention, site compliance, and overall patient experience. The company's client roster includes notable organizations in the pharmaceutical and medical device sectors, such as Array Biopharma, Genentech, Actelion, Takeda, and Boston Scientific.

IMTherapeutics is a biotechnology company focused on creating personalized immunotherapeutic drugs for autoimmune diseases, utilizing genetic insights linked to human leukocyte antigen (HLA) genes. Founded in 2015 and based in Aurora, Colorado, the company’s lead candidate is an oral medication designed to inhibit the autoimmune process in type 1 diabetes (T1D) by targeting specific immune cells. This approach aims to preserve the function of pancreatic beta cells and support normal insulin production in patients at risk or in the early stages of T1D. Additionally, IMTherapeutics is leveraging its HLA platform to expand its drug pipeline to include treatments for Celiac disease and potentially other autoimmune disorders. The company employs advanced screening techniques and rational drug design to develop targeted therapeutic candidates, enhancing early detection and management of autoimmune conditions.

Carta Healthcare, Inc. is a technology company that specializes in developing a software-as-a-service platform aimed at improving hospital patient management. Founded in 2016 and headquartered in San Mateo, California, the company leverages data from existing IT systems to map the patient journey through hospitals. Its platform utilizes machine learning to identify similarities between current patients and past patients, allowing healthcare providers to personalize care based on individual needs. Additionally, it predicts potential bottlenecks, such as recovery bed shortages and cancellations, offering alerts that help hospitals optimize their operations. By combining artificial intelligence with human expertise, Carta Healthcare enhances the efficiency and quality of healthcare data management, ultimately aiming to provide a better experience for patients.